Official UK procurement notice
NHSE - NEL Provision of Covid-19 Vaccination Services - 2
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionNHSE - NEL Provision of Covid-19 Vaccination Services - 2.
CPV: Miscellaneous health services
The lotProcurement structure
single lot · no lot value publishedLot #1NHSE - NEL Provision of Covid-19 Vaccination Services - 2Awarded
NHSE - NEL Provision of Covid-19 Vaccination Services - 2.
To provide a centralised team for co-ordinating innovative approaches to outreach across the NEL boroughs of Redbridge, Hackney and the City of London, Havering, Waltham Forest, Tower Hamlets, Newham & Barking and Dagenham.
Work collaboratively with system communications and engagement teams, local public health teams, housing teams, place-based teams, voluntary sector organisations, faith groups, experts by experience and community groups in co-designing outreach clinics, events and interventions to address health inequalities and increase vaccine uptake.
To reduce health inequalities by reaching eligible cohorts in underserved individuals and/or communities and inclusion groups;
To co-design outreach clinics that build trust and increase vaccination uptake amongst eligible inclusion health groups as defined by the National framework for NHS - action on inclusion health.
To offer a flexible and responsive outreach service that offers a targeted approach to outreach, based on local data analysis and behavioural insights.
To actively participate in community engagement initiatives that build trust and confidence in vaccination programmes.
Develop a robust communication plan in partnership with the ICB, local authority, local stakeholders and pan London Vaccination and Screening Steering Groups and health partnerships to raise awareness and promote vaccination uptake.
To implement systems and processes to ensure that the outreach team is up to date and informed of any changes to national guidance, policy and protocols in relation to the safe and effective delivery of national vaccination programmes.
This contract award has been made following Urgent Award Process (The Health Care Services (Provider Selection Regime) Regulations 2023, Regulation 14).
This contract will be for the period 1st April 2025 to 31st March 2026 (12 months).
The approximate lifetime value of the contract for 12 months is £178,750.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 9 Apr 2025, 13:17 BST
- Last source update
- 9 Apr 2025, 13:17 BST
- Authority reference
PRJ2173- FTS notice number
2025/S 000-013959- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04ffa3Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
This an incumbent provider within the NEL footprint, having taken part in previous campaigns. A delay in national confirmation of funding created an unrealistic timeframe, in which a full procurement process would have left gaps in the provision of vaccines in the upcoming Spring campaign for large numbers of eligible individuals and/or groups. Discussion has taken place with all London ICB Programme Leads and it has been agreed that due to the serious time constraints and ensuring readiness for Spring, a direct award of 12 months to incumbent providers is essential. In addition, there is significant concern on the extent of reduction in Access and Inequalities funding, and with no surge budget this year, that providers will not come forward to support any shorter contract period as it is not financially viable for them. It is recommended that regional approval is provided to issue direct award contracts to existing incumbent providers to enable the commissioning of outreach services for 2025/26.
Publisher note: This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This an incumbent provider within the NEL footprint, having taken part in previous campaigns. A delay in national confirmation of funding created an unrealistic timeframe, in which a full procurement process would have left gaps in the provision of vaccines in the upcoming Spring campaign for large numbers of eligible individuals and/or groups. Discussion has taken place with all London ICB Programme Leads and it has been agreed that due to the serious time constraints and ensuring readiness for Spring, a direct award of 12 months to incumbent providers is essential. In addition, there is significant concern on the extent of reduction in Access and Inequalities funding, and with no surge budget this year, that providers will not come forward to support any shorter contract period as it is not financially viable for them. It is recommended that regional approval is provided to issue direct award contracts to existing incumbent providers to enable the commissioning of outreach services for 2025/26. Award decision makers: Following a national CEG decision, the London Regional Executive team approved the request for an Outreach Service, Direct Award (12 months) to incumbent providers. - Regional Director of Finance, NHSE London - Regional Director of Commissioning, NHSE London - Director of Commissioning Finance, NHSE London Approval was also given by: - Operational Director - Covid-19 and Influenza Vaccination Programmes, NHSE London - Assistant Director of Delivery, NHSE London - Vaccine Programme Lead, NHSE London There were no conflicts of interest identified in the decision making process.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Richmond Road Medical Centre London | £178,750 † | — | Awarded |
Contracts
Contract 013959-2025-1 · Richmond Road Medical Centre London
- Signed
- 25 Feb 2025
- Value
- £178,750
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Richmond Road Medical Centre LondonAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.